Dr. Turaga Discusses Current Surgical Setting of Sarcoma

Video

Kiran Turaga, MD, MPH, surgical oncologist, University of Chicago Cancer Center, discusses the current surgical setting of sarcoma.

Kiran Turaga, MD, MPH, surgical oncologist, University of Chicago Cancer Center, discusses the current surgical setting of sarcoma.

Although surgical resection remains standard for patients with retroperitoneal sarcomas, Turaga says, the concept of compartmental resection is being explored once again.

Recently, adjuvant systemic chemotherapy was explored in patients with sarcomas, but the data was not strong for sarcomas as a group, says Turaga. There does seem to be benefits in some subgroups, such as leiomyosarcoma.

Additionally, the recent investigation into the use of multi-receptor TKIs, such as pazopanib (Votrient), is interesting, Turaga says.

Related Videos
Josep Maria Piulats Rodriguez, MD, PhD
Samer A. Srour, MB ChB, MS
William B. Pearse, MD
Núria Agustí Garcia, MD
Mikkael A. Sekeres, MD, MS
Benjamin Levy, MD
Alessandra Ferrajoli, MD
Saad Z. Usmani, MD, MBA, FACP, FASCO, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center
Petros Grivas, MD, PhD, professor, Clinical Research Division, Fred Hutchinson Cancer Center; professor, Division of Hematology and Oncology, University of Washington (UW) School of Medicine; clinical director, Genitourinary Cancers Program, UW Medicine
Somedeb Ball, MBBS, assistant professor, medicine, Division of Hematology Oncology, Department of Medicine, Vanderbilt University Medical Center